Profile
Joy Greer's former jobs include being an Executive Director of Clinical Research at Gilead Sciences, Inc., a Senior Director of Clinical Science at Annexon, Inc., and a Senior Director of Clinical Operations at Acerta Pharma LLC.
Additionally, Dr. Greer served as the Vice President of Clinical Science at Vincerx Pharma, Inc. from 2021 to 2022.
Dr. Greer obtained a doctorate degree from the University of Utah and an undergraduate degree from the University of Wyoming.
Former positions of Joy Greer
| Companies | Position | End |
|---|---|---|
| VINCERX PHARMA, INC. | Chief Tech/Sci/R&D Officer | 01/06/2022 |
Acerta Pharma LLC
Acerta Pharma LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that specializes in drug development | Chief Tech/Sci/R&D Officer | - |
| GILEAD SCIENCES, INC. | Chief Tech/Sci/R&D Officer | - |
| ANNEXON, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Joy Greer
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 6 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Annexon, Inc.
Annexon, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurodegenerative and autoimmune disorders | Health Technology |
University of Utah
University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wyoming
University of Wyoming Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acerta Pharma LLC
Acerta Pharma LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that specializes in drug development | Health Technology |
Vincerx Pharma, Inc.
Vincerx Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies to address cancer | Health Technology |
- Stock Market
- Insiders
- Joy Greer
















